U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku

Accolade

10/10/2024 07:39

Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.

  HIGHLIGHTS       
                 * Abbott  ABT.N : JP Morgan raises target price to $135 from $125
 
                 * Gilead  GILD.O : Raymond James raises target price to $95 from $94
 
                 * Roku Inc  ROKU.O : JP Morgan raises target price to $92 from $90
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in
alphabetical order.   
    
                 * 10X Genomics Inc  TXG.O : Leerink Partners cuts target price to $25 from $35
 
                 * Abbott  ABT.N : JP Morgan raises target price to $135 from $125
 
                 * Accolade Inc  ACCD.O : Raymond James cuts target price to $7 from $11
 
                 * Clearside Biomedical Inc  CLSD.O : Needham raises target price to $6 from $4
 
                 * Costco Wholesale Corp  COST.O : Oppenheimer raises target price to $980 from $955
 
                 * Gilead  GILD.O : Raymond James raises target price to $95 from $94
 
                 * IBM  IBM.N : RBC raises target price to $250 from $211
 
                 * Moody's Corp  MCO.N : RBC raises target price to $535 from $475
 
                 * Onemain Holdings Inc  OMF.N : RBC cuts target price to $58 from $60
 
                 * Roku Inc  ROKU.O : JP Morgan raises target price to $92 from $90
 
                 * S&P Global Inc  SPGI.N : RBC raises target price to $595 from $552
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))